Extended Use of Automated Insulin Delivery in Young People with Type 1 Diabetes and Elevated HbA1c: 52-Week Outcomes of the CO-PILOT Trial
EndocrinologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- Diabetes technology & therapeutics
- Publicado em
- 5 mar 2026
- Citações
- 3
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Extended Use of Automated Insulin Delivery in Young People with Type 1 Diabetes and Elevated HbA1c: 52-Week Outcomes of the CO-PILOT Trial
Marcus C Ward, Alisa Boucsein, Yongwen Zhou, Venus R Michaels, Jillian J Haszard, Craig A Jefferies, Esko J Wiltshire, Ryan G Paul, Caleb A Lopez-Sanchez, Martin I de Bock et al.
Descritores MeSH
- Insulin Infusion Systems
- Diabetes Mellitus, Type 1
- Glycated Hemoglobin
- Hypoglycemic Agents
- Insulin
- Female
- Humans
- Hypoglycemia
- Male
- Pilot Projects
Veja também
Estudos relacionados
- Efficacy and Safety of Tubeless Hybrid Closed-Loop Systems in Type 1 Diabetes: A Meta-Analysis of Randomized Controlled Trials
- Efficacy and safety of automated insulin delivery system in very young children with type 1 diabetes: A systematic review and meta-analysis of randomized controlled trials
- Hybrid Closed-Loop Disconnection Reduces the Risk of Hypoglycemia in Active Children and Adolescents with Type 1 Diabetes: A Randomized Controlled Pilot Study
- Closed-Loop Insulin Delivery in Type 1 Diabetes in Pregnancy: The CIRCUIT Randomized Clinical Trial